Choreo LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.18M Buy
59,321
+7,968
+16% +$763K 0.06% 213
2025
Q4
$4.96M Sell
51,353
-546
-1% -$53K 0.06% 200
2025
Q3
$4.98M Buy
51,899
+3,521
+7% +$324K 0.06% 205
2025
Q2
$4.25M Buy
48,378
+4,413
+10% +$374K 0.06% 221
2025
Q1
$3.97M Sell
43,965
-9,852
-18% -$882K 0.06% 214
2024
Q4
$3.99M Buy
53,817
+4,799
+10% +$415K 0.06% 223
2024
Q3
$4.44M Buy
49,018
+1,475
+3% +$124K 0.07% 204
2024
Q2
$3.68M Buy
47,543
+32,709
+221% +$2.68M 0.06% 205
2024
Q1
$1.29M Buy
14,834
+386
+3% +$32.9K 0.03% 236
2023
Q4
$1.2M Sell
14,448
-168
-1% -$12.8K 0.03% 232
2023
Q3
$1.16M Buy
14,616
+1,815
+14% +$152K 0.04% 185
2023
Q2
$1.14M Buy
12,801
+3
+0% +$258 0.04% 190
2023
Q1
$1.03M Buy
12,798
+8,195
+178% +$668K 0.04% 204
2022
Q4
$358K Buy
4,603
+241
+6% +$19.5K 0.02% 174
2022
Q3
$352K Sell
4,362
-808
-16% -$72.6K 0.02% 154
2022
Q2
$464K Buy
5,170
+1,428
+38% +$145K 0.03% 133
2022
Q1
$415K Buy
3,742
+91
+2% +$9.61K 0.02% 156
2021
Q4
$378K Buy
3,651
+183
+5% +$21.2K 0.02% 163
2021
Q3
$435K Buy
3,468
+346
+11% +$44.8K 0.02% 144
2021
Q2
$388K Buy
+3,122
New +$392K 0.02% 153

Other funds holding MDT

Choreo LLC's MDT Position: Q1 2026 in Review

Choreo LLC increased its Medtronic (MDT) stake by 16% in Q1 2026, buying an estimated $763K and bringing the position to 59,321 shares worth $5.18M. The position accounts for 0.06% of the portfolio, ranked #213.

Choreo LLC first reported a position in MDT in Q2 2021 and has held it in 20 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Choreo LLC held 59,321 shares of Medtronic worth $5.18M as of Q1 2026.
  • Choreo LLC bought 7,968 Medtronic shares in Q1 2026, an estimated $763K.
  • Medtronic made up 0.06% of Choreo LLC's portfolio in Q1 2026, its #213 holding.
  • Choreo LLC first reported a position in Medtronic in Q2 2021 and has held it in 20 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.